China healthcare Global Markets Research EQUITY: HEALTH CARE & PHARMACEUTICALS Geopolitical concerns re-emerge... ...this time on out-licensing of drugs What is new? The New York Times has reported that Trump administration is potentially contemplating curbs on medicines from China On 10 September morning (ET), the NYT reported that the Trump administration has been discussing placing stringent restrictions on medicines from China, including clinical- stage molecules and generics. The article reported that ...